Significance of Clinical trials registry – India
The Clinical Trials Registry - India (CTRI) serves as a crucial online platform for registering all clinical trials conducted in India, including those related to traditional medicine and AYUSH studies for COVID-19. It is part of the WHO's International Clinical Trials Registry Platform and ensures that trials adhere to formal protocols and ethical standards. Overseen by the Indian Council of Medical Research and the NIMS, CTRI aims to promote transparency and accountability in clinical research within the country.
The below excerpts are indicatory and do represent direct quotations or translations. It is your responsibility to fact check each reference.
The concept of Clinical trials registry – India in scientific sources
The Clinical Trials Registry – India (CTRI) serves as a key platform for documenting clinical trials in India, promoting research ethics and transparency. It is a primary registry under WHO's International Clinical Trials Registry Platform, encompassing various medical fields.
(1) The CTRI is a free, online primary register of the WHO's International Clinical Trials Registry Platform that facilitates the registration of all clinical trials conducted in India, including those for traditional medicine.[1] (2) CTRI is one of the primary registries under ICTRP that collects information on clinical trials conducted in India.[2] (3) A platform that maintains records of clinical trials conducted in India to promote ethical conduct in research.[3]
(1) A registry that documents and manages clinical trials conducted in India, particularly in the context of AYUSH studies for COVID-19.[4] (2) CTRI is a free and online public record domain for registration of clinical trials conducted in India, initiated by the Indian Council of Medical Research and monitored by the NIMS.[5]
(1) A database where the study was registered, ensuring its conduct adhered to formal protocols and standards.[6]